Published by Josh White on 20th January 2021
(Sharecast News) - Alliance Pharma said on Wednesday that its see-through revenues for 2020 were down 5% on the prior year at £137.5m, as expected, both on a reported and a constant currency basis, reflecting the impact of Covid-19.
URL: http://www.digitallook.com/dl/news/story/31589439/...